Published in Circ Res on June 17, 2010
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov (2011) 3.08
ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res (2011) 2.03
Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes (2014) 1.85
Under pressure: the search for the essential mechanisms of hypertension. Nat Med (2011) 1.72
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc Res (2012) 1.63
Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension. Circ Res (2015) 1.60
Involvement of bone marrow cells and neuroinflammation in hypertension. Circ Res (2015) 1.54
Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension (2011) 1.48
Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One (2012) 1.43
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol (2013) 1.39
Excessive Adventitial Remodeling Leads to Early Aortic Maladaptation in Angiotensin-Induced Hypertension. Hypertension (2016) 1.38
Vascular inflammatory cells in hypertension. Front Physiol (2012) 1.37
Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res (2013) 1.35
Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension (2012) 1.33
Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension (2014) 1.32
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res (2012) 1.19
Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension. PLoS One (2013) 1.15
Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension (2014) 1.12
The immune system and hypertension. Immunol Res (2014) 1.10
Recent advances involving the renin-angiotensin system. Exp Cell Res (2012) 1.09
Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol (2013) 1.08
Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol (2011) 1.07
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ Res (2013) 1.07
Hypertensive crisis in children. Pediatr Nephrol (2011) 1.07
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic Biol Med (2011) 1.05
The immune system in hypertension. Trans Am Clin Climatol Assoc (2014) 1.05
The central nervous system and inflammation in hypertension. Curr Opin Pharmacol (2010) 1.03
Vascular inflammation and endothelial dysfunction in experimental hypertension. Int J Hypertens (2011) 1.03
T lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biol Psychiatry (2012) 1.03
The immune system in hypertension. Adv Physiol Educ (2014) 1.03
Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation. J Neuroinflammation (2012) 1.02
Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease. Steroids (2014) 1.01
Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol (2013) 1.00
Carotid sinus denervation ameliorates renovascular hypertension in adult Wistar rats. J Physiol (2016) 1.00
Pressure natriuresis and the renal control of arterial blood pressure. J Physiol (2014) 0.98
Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities. Int J Hypertens (2012) 0.97
Integrative network analysis reveals molecular mechanisms of blood pressure regulation. Mol Syst Biol (2015) 0.95
Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension. Hypertension (2012) 0.95
Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-sensitive hypertension. Am J Physiol Renal Physiol (2012) 0.95
Dual opposing roles of adaptive immunity in hypertension. Eur Heart J (2014) 0.95
Immune Mechanisms in Arterial Hypertension. J Am Soc Nephrol (2015) 0.94
The immunological basis of hypertension. Am J Hypertens (2014) 0.94
Role of T lymphocytes in hypertension. Curr Opin Pharmacol (2014) 0.93
Classical Renin-Angiotensin system in kidney physiology. Compr Physiol (2014) 0.92
Intravital Förster resonance energy transfer imaging reveals elevated [Ca2+]i and enhanced sympathetic tone in femoral arteries of angiotensin II-infused hypertensive biosensor mice. J Physiol (2013) 0.91
The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension. J Am Soc Hypertens (2013) 0.91
Sympathetic overactivity occurs before hypertension in the two-kidney, one-clip model. Exp Physiol (2015) 0.91
Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension. J Physiol (2015) 0.90
Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats. Cardiovasc Res (2015) 0.90
Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol Psychiatry (2013) 0.89
Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans. Hypertension (2016) 0.89
Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats. Am J Physiol Renal Physiol (2011) 0.88
Excessive leukotriene B4 in nucleus tractus solitarii is prohypertensive in spontaneously hypertensive rats. Hypertension (2012) 0.88
Osmoregulatory thirst in mice lacking the transient receptor potential vanilloid type 1 (TRPV1) and/or type 4 (TRPV4) receptor. Am J Physiol Regul Integr Comp Physiol (2014) 0.86
Neuroimmune communication in hypertension and obesity: a new therapeutic angle? Pharmacol Ther (2013) 0.85
Angiotensin-II, the Brain, and Hypertension: An Update. Hypertension (2015) 0.84
Darkness at the end of the tunnel: poststenotic kidney injury. Physiology (Bethesda) (2013) 0.83
Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics. Circ Res (2016) 0.82
Brain inflammation and hypertension: the chicken or the egg? J Neuroinflammation (2015) 0.82
The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases. Curr Hypertens Rep (2013) 0.81
Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease. Hypertension (2014) 0.81
Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration. Free Radic Biol Med (2014) 0.81
Sex-specific immune modulation of primary hypertension. Cell Immunol (2014) 0.81
HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation. Hypertension (2013) 0.81
T cells and blood vessels: costimulation turns up the pressure. Circulation (2010) 0.80
Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats. Am J Hypertens (2016) 0.80
Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol (2017) 0.79
Redox-regulated suppression of splenic T-lymphocyte activation in a model of sympathoexcitation. Hypertension (2015) 0.79
Stress-dependent hypertension and the role of T lymphocytes. Exp Physiol (2012) 0.79
The Association Between Glycosylation of Immunoglobulin G and Hypertension: A Multiple Ethnic Cross-Sectional Study. Medicine (Baltimore) (2016) 0.79
Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear. Genes Brain Behav (2015) 0.79
Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension. Cardiovasc Res (2012) 0.79
Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress. PLoS One (2015) 0.78
Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension. Curr Hypertens Rep (2013) 0.78
Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response. PLoS One (2013) 0.78
Primary hypertension in children and adolescents is an immuno-metabolic disease with hemodynamic consequences. Curr Hypertens Rep (2013) 0.77
Macrophage depletion lowers blood pressure and restores sympathetic nerve α2-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol (2015) 0.77
Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol (2016) 0.77
Macrophages in neuroinflammation: role of the renin-angiotensin-system. Pflugers Arch (2017) 0.77
Role of immune cells in salt-sensitive hypertension and renal injury. Curr Opin Nephrol Hypertens (2016) 0.76
Hypertension and immunity: mechanisms of T cell activation and pathways of hypertension. Curr Opin Nephrol Hypertens (2015) 0.76
Dysregulation of T cell subsets in the pathogenesis of hypertension. Curr Hypertens Rep (2015) 0.76
Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension. J Physiol (2015) 0.76
Inflammation and neurogenic hypertension: a new role for the circumventricular organs? Circ Res (2010) 0.76
Atherosclerotic renal artery stenosis: current status. Adv Chronic Kidney Dis (2015) 0.76
P‑selectin increases angiotensin II‑induced cardiac inflammation and fibrosis via platelet activation. Mol Med Rep (2016) 0.75
Tooth Loss and Metabolic Syndrome in South Korea: The 2012 Korean National Health and Nutrition Examination Survey. Medicine (Baltimore) (2016) 0.75
Systemic leukotriene B4 receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat. J Physiol (2016) 0.75
Is microglia the new target for the treatment of resistant hypertension? Hypertension (2015) 0.75
Recent advances in central cardiovascular control: sex, ROS, gas and inflammation. F1000Res (2016) 0.75
Renal Denervation Normalizes Arterial Pressure With No Effect on Glucose Metabolism or Renal Inflammation in Obese Hypertensive Mice. Hypertension (2016) 0.75
Expression of Adiponectin Receptors on Peripheral Blood Leukocytes of Hypertensive Children Is Associated with the Severity of Hypertension. Biomed Res Int (2015) 0.75
Vascular Damage in Resistant Hypertension: TNF-Alpha Inhibition Effects on Endothelial Cells. Biomed Res Int (2015) 0.75
A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat Commun (2016) 0.75
Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms. Hypertension (2017) 0.75
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69
The sympathetic control of blood pressure. Nat Rev Neurosci (2006) 6.44
Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res (2004) 4.12
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension (2009) 3.06
T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol (2004) 2.96
Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol (2004) 2.94
ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol (2009) 2.01
Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol (2002) 1.89
Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev (2001) 1.86
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension (2009) 1.86
Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol (2008) 1.51
Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. J Clin Invest (1996) 1.46
Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Am J Physiol Heart Circ Physiol (2005) 1.44
Afferent connections of the median preoptic nucleus in the rat: anatomical evidence for a cardiovascular integrative mechanism in the anteroventral third ventricular (AV3V) region. Brain Res (1983) 1.43
Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol (2004) 1.33
Investigations on the physiological controls of water and saline intake in C57BL/6 mice. Am J Physiol Regul Integr Comp Physiol (2003) 1.09
Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol (2007) 1.08
K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr Pharm Des (2006) 1.03
Central nervous system and mechanisms of hypertension. Clin Physiol Biochem (1988) 1.02
Vascular-brain signaling in hypertension: role of angiotensin II and nitric oxide. Curr Hypertens Rep (2007) 1.01
Preoptic-hypothalamic periventricular lesions: thirst deficits and hypernatremia. Am J Physiol (1977) 0.98
Neuro-cardiovascular regulation: from molecules to man. Introduction. Ann N Y Acad Sci (2001) 0.96
Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels. Eur J Pharmacol (1998) 0.95
Angiotensin-induced thirst: effects of third ventricle obstruction and periventricular ablation. Brain Res (1978) 0.93
Interruption of the maintenance phase of established hypertension by ablation of the anteroventral third ventricle (AV3V) in rats. Clin Exp Hypertens (1980) 0.90
Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol (2008) 0.87
Lesions of the anteroventral third ventricle region (AV3V) disrupt cardiovascular responses to an elevation in core temperature. Am J Physiol Regul Integr Comp Physiol (2005) 0.84
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med (2007) 7.69
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest (2003) 6.30
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res (2007) 4.48
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem (2003) 3.23
Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension (2002) 3.23
Measurement of reactive oxygen species in cardiovascular studies. Hypertension (2007) 3.17
Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res (2010) 3.16
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci (2003) 3.13
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension (2009) 3.06
Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation (2010) 2.95
Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am J Physiol Cell Physiol (2004) 2.94
Role of extracellular superoxide dismutase in hypertension. Hypertension (2006) 2.74
Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med (2008) 2.68
ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol (2004) 2.45
Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol (2008) 2.44
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res (2005) 2.29
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol (2011) 2.27
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation (2002) 2.22
Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol (2003) 2.09
Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem (2003) 2.09
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation (2004) 2.07
Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation (2005) 2.02
Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis (2005) 2.02
Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res (2007) 2.01
Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol (2008) 1.98
Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest (2013) 1.92
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest (2015) 1.89
Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res (2009) 1.88
Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation (2002) 1.87
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension (2009) 1.86
Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease. Circ Res (2004) 1.84
Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol (2002) 1.81
Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. Am J Physiol Heart Circ Physiol (2007) 1.81
The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation (2002) 1.72
Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol (2005) 1.72
Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res (2002) 1.68
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation (2010) 1.68
Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol (2005) 1.66
Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension (2013) 1.65
Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today (2006) 1.59
DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest (2014) 1.59
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol (2006) 1.59
Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol (2007) 1.57
Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest (2015) 1.55
Requirement of argininosuccinate lyase for systemic nitric oxide production. Nat Med (2011) 1.54
NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem (2002) 1.53
Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol (2008) 1.51
Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation (2006) 1.50
Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation (2004) 1.50
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol (2007) 1.47
The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res (2005) 1.46
Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation (2003) 1.45
Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol (2002) 1.44
RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension (2006) 1.41
Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol (2003) 1.41
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation (2003) 1.40
Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J Biol Chem (2003) 1.36
Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res (2013) 1.35
Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension (2012) 1.33
Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation (2011) 1.31
Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol (2010) 1.31
Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res (2009) 1.29
Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2004) 1.29
Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension (2012) 1.28
Role of antioxidant-1 in extracellular superoxide dismutase function and expression. Circ Res (2005) 1.27
A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol (2005) 1.27
Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol (2004) 1.26
Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal (2013) 1.26
Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitric-oxide synthase. J Biol Chem (2002) 1.24
Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training. Am J Physiol Heart Circ Physiol (2002) 1.23
Early determinants of H2O2-induced endothelial dysfunction. Free Radic Biol Med (2006) 1.22
Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol (2012) 1.20
Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal (2012) 1.20
Role of Menkes ATPase in angiotensin II-induced hypertension: a key modulator for extracellular superoxide dismutase function. Hypertension (2008) 1.19
NADPH oxidases in vascular pathology. Antioxid Redox Signal (2013) 1.17
Endothelial NO synthase phosphorylated at SER635 produces NO without requiring intracellular calcium increase. Free Radic Biol Med (2003) 1.16
Is hypertension an immunologic disease? Curr Cardiol Rep (2008) 1.15
Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension (2008) 1.15